Conotoxin GID unbinding pathways between alpha7 and alpha4beta2 nicotinic acetylcholine receptor subtypes were identified. Receptor-conotoxin interactions were identified which may explain the difference in potency of GID at alpha7 and alpha4beta2. Single-site mutations were proposed on GID which may enhance its selectivity for the alpha4beta2 receptor subtype.